DAVID ROY BANGSBERG

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda
    Elvin H Geng
    Division of HIV AIDS, Department of Medicine, San Francisco General Hospital, San Francisco, California, USA
    PLoS ONE 5:e14098. 2010
  2. pmc Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards
    Anna Baylor
    Massachusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America Mbarara University of Science and Technology, Mbarara, Uganda
    PLoS Med 10:e1001397. 2013
  3. pmc Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western Uganda
    Francis Bajunirwe
    Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda
    BMC Public Health 13:430. 2013
  4. pmc High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study
    Mark J Siedner
    Department of Infectious Disease, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, GRJ 5, Boston, MA 02114, USA
    BMC Med Inform Decis Mak 12:56. 2012
  5. pmc Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, Geneva, Switzerland
    BMC Infect Dis 12:147. 2012
  6. pmc Potential for false positive HIV test results with the serial rapid HIV testing algorithm
    Steven Baveewo
    Department of Medicine, Makerere University School of Medicine, Kampala, Uganda
    BMC Res Notes 5:154. 2012
  7. pmc Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009
    Elvin H Geng
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, San Francisco, CA, USA
    J Int AIDS Soc 14:46. 2011
  8. pmc A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people
    David R Bangsberg
    Massachusetts General Hospital Center for Global Health, Ragon Institute of MGH, MIT, and Harvard, Harvard Medical School, Boston, USA
    AIDS 24:2835-40. 2010
  9. pmc A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV
    Alexander C Tsai
    Langley Porter Psychiatric Institute, University of California at San Francisco, USA
    Arch Gen Psychiatry 67:1282-90. 2010

Collaborators

  • Alexander C Tsai
  • Jessica E Haberer
  • Elvin H Geng
  • Lynn T Matthews
  • Peter W Hunt
  • Francis Bajunirwe
  • Anna Baylor
  • Alexandra Calmy
  • Mark J Siedner
  • Steven Baveewo
  • Conrad Muzoora
  • Jeffrey N Martin
  • Annet Kembabazi
  • Ajay K Sethi
  • Mwebsa Bwana
  • Andrew Boulle
  • Matthias Egger
  • Mauro Schechter
  • Robin Wood
  • Carlos Zala
  • N Kumarasamy
  • Stefaan van der Borght
  • Eric Balestre
  • Judith A Hahn
  • Francois Dabis
  • Rodolphe Thiebaut
  • Rhoda K Wanyenze
  • Thomas Coates
  • Harriet Mayanja-Kizza
  • Norma C Ware
  • James Mcintyre
  • Patrick McPhail
  • Kamal Marhoum El Filali
  • Mwebesa Bosco Bwana
  • Moses R Kamya
  • Eric Delaporte
  • Eduardo Sprinz
  • Eugene Messou
  • Robin Fatch
  • Fabrice Bonnet

Detail Information

Publications9

  1. pmc Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda
    Elvin H Geng
    Division of HIV AIDS, Department of Medicine, San Francisco General Hospital, San Francisco, California, USA
    PLoS ONE 5:e14098. 2010
    ..The impact of flat-line funding in the global scale up of antiretroviral therapy (ART) for HIV-infected patients in Africa has not yet been well described...
  2. pmc Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards
    Anna Baylor
    Massachusetts General Hospital Center for Global Health, Boston, Massachusetts, United States of America Mbarara University of Science and Technology, Mbarara, Uganda
    PLoS Med 10:e1001397. 2013
    ..David Bangsberg and colleagues explore the challenges and rewards of sharing research findings with participants living with HIV enrolled in observational research in rural sub-Saharan Africa...
  3. pmc Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western Uganda
    Francis Bajunirwe
    Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda
    BMC Public Health 13:430. 2013
    ..We determined the correlates of sexual activity and high-risk sexual behavior in an ART-treated population in rural and urban Uganda...
  4. pmc High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study
    Mark J Siedner
    Department of Infectious Disease, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, GRJ 5, Boston, MA 02114, USA
    BMC Med Inform Decis Mak 12:56. 2012
    ....
  5. pmc Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, Geneva, Switzerland
    BMC Infect Dis 12:147. 2012
    ..We assessed the impact of on-going HIV-RNA replication on CD4 cell count slopes in patients treated with a first-line combination ART...
  6. pmc Potential for false positive HIV test results with the serial rapid HIV testing algorithm
    Steven Baveewo
    Department of Medicine, Makerere University School of Medicine, Kampala, Uganda
    BMC Res Notes 5:154. 2012
    ..We conducted further testing on this subgroup of samples using qualitative DNA PCR to assess the potential for false positive tests in this situation...
  7. pmc Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009
    Elvin H Geng
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, San Francisco, CA, USA
    J Int AIDS Soc 14:46. 2011
    ..Regionally representative socio-demographic, laboratory and clinical characteristics of patients accessing ART over time and across sites have not been well described...
  8. pmc A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people
    David R Bangsberg
    Massachusetts General Hospital Center for Global Health, Ragon Institute of MGH, MIT, and Harvard, Harvard Medical School, Boston, USA
    AIDS 24:2835-40. 2010
    ..The virologic effectiveness of this STR in a potentially nonadherent population remains a concern, given the rapid selection of drug resistance seen with these drugs...
  9. pmc A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV
    Alexander C Tsai
    Langley Porter Psychiatric Institute, University of California at San Francisco, USA
    Arch Gen Psychiatry 67:1282-90. 2010
    ..Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial...

Research Grants18

  1. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2001
    ..We will examine five primary aims, including depression treatment, adherence to antiretroviral therapy, duration of sustained antiretroviral treatment, initiation of treatment, and viral suppression. ..
  2. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2006
    ..To better guide therapy in both settings, these studies will further our understanding of drug resistance, including its causes, its extent and the role it plays in disease progression and death. ..
  3. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2005
    ..To better guide therapy in both settings, these studies will further our understanding of drug resistance, including its causes, its extent and the role it plays in disease progression and death. ..
  4. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2004
    ..We will examine five primary aims, including depression treatment, adherence to antiretroviral therapy, duration of sustained antiretroviral treatment, initiation of treatment, and viral suppression. ..
  5. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2004
    ..Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect. ..
  6. HIV Treatment in the homeless: a prospective study
    David Bangsberg; Fiscal Year: 2004
    ..The proposed research will assist in the development of both behavioral and therapeutic strategies to extend treatment and reduce the risk of drug resistance in this important population. ..
  7. Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
    DAVID ROY BANGSBERG; Fiscal Year: 2010
    ..Thus, this study has the potential to transform HIV practice in both resource-limited and resource-rich settings, including the US. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page ..
  8. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2002
    ..We will examine five primary aims, including depression treatment, adherence to antiretroviral therapy, duration of sustained antiretroviral treatment, initiation of treatment, and viral suppression. ..
  9. HIV Treatment in the homeless: a prospective study
    David Bangsberg; Fiscal Year: 2003
    ..The proposed research will assist in the development of both behavioral and therapeutic strategies to extend treatment and reduce the risk of drug resistance in this important population. ..
  10. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2005
    ..Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect. ..
  11. Depression Treatment to Improve ARV Therapy Adherence
    David Bangsberg; Fiscal Year: 2003
    ..We will examine five primary aims, including depression treatment, adherence to antiretroviral therapy, duration of sustained antiretroviral treatment, initiation of treatment, and viral suppression. ..
  12. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2007
    ..To better guide therapy in both settings, these studies will further our understanding of drug resistance, including its causes, its extent and the role it plays in disease progression and death. ..
  13. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2003
    ..Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect. ..
  14. International HIV ARV Adherence, Resistance and Survival
    David Bangsberg; Fiscal Year: 2009
    ..To better guide therapy in both settings, these studies will further our understanding of drug resistance, including its causes, its extent and the role it plays in disease progression and death. ..
  15. A RCT of HIV Adherence Case Management and Modified DOT
    David Bangsberg; Fiscal Year: 2006
    ..Outcomes will be assessed quarterly during the 6-month intervention and during a 6 month post-intervention period to examine the durability of the intervention effect. ..